This is a firm-fixed-price purchase order awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $1,008,529.39, is for a cost-per-stain lease of an immunohistochemistry (IHC) staining platform to support the Department of Pathology at Madigan Army Medical Center in Tacoma, Washington. This is a new 5-year contract, with a base period...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $262,962.36 contract is for the supply of reagents and consumables to support the government-owned Roche b221 blood gas analyzers at Madigan Army Medical Center, Joint Base Lewis-McChord in Washington. The contract has a period of performance through September 30, 2025. This...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The $1,386,061.00 contract is for the provision of instrumentation and reagents to perform immunohistochemical (IHC) and histology special staining testing services. The contract has an ultimate completion date of September 30, 2025 and was awarded on March 7, 2021. It...
This is a federal contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide a lease of a slide staining platform. The contract has a ceiling value of $362,038.75 and a period of performance from October 1, 2021 through September 30, 2026. The contract is a firm fixed price purchase order, with no set-aside designation. The contract was awarded under a pre-solicitation that was posted in May 2021, seeking two...
This is a $356,375.00 delivery order contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for IHC cost-per-test, slide stainer, cytology/histology reagents, and consumables in support of the Naval Medical Center in Portsmouth, Virginia. The contract is a firm-fixed-price, non-set-aside contract with a period of performance ending on March 23, 2021. Roche...
This is a $1,971,670.21 firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of cancer antibodies and reagents, with a period of performance running through September 30, 2028. The contract is not designated as a set-aside and is part of Roche's existing portfolio of federal contracts, which...
This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $712,750.00, was awarded by the Defense Health Agency (DHA) for "IHC COST PER TEST" services. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract vehicle, likely a Blanket Purchase Agreement (BPA) or Indefinite...
This federal contract award is for the Department of Veterans Affairs (VA) Veterans Health Administration to acquire immunohistochemistry (IHC) special stains from Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract is a firm fixed-price purchase order with a potential value of $202,161.24 and a completion date of November 30, 2021. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $2,570,023.23 contract is for the provision of histology services and does not have a set-aside designation. Roche Diagnostics has extensive experience as both a prime contractor and subcontractor providing critical medical...
This firm-fixed-price delivery order contract was awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 8, to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $62,676.00, is for immunohistochemical special stains services, with a period of performance through February 1, 2024. Roche Diagnostics is a...